Vontobel Holding Ltd. Sells 5,423 Shares of Billiontoone, Inc. $BLLN

Vontobel Holding Ltd. trimmed its position in Billiontoone, Inc. (NASDAQ:BLLN) by 35.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,700 shares of the company’s stock after selling 5,423 shares during the quarter. Vontobel Holding Ltd.’s holdings in Billiontoone were worth $1,032,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Wasatch Advisors LP increased its position in Billiontoone by 40.2% during the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after buying an additional 148,446 shares during the last quarter. Emerald Advisers LLC boosted its stake in shares of Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after acquiring an additional 50,613 shares during the period. Emerald Mutual Fund Advisers Trust boosted its stake in shares of Billiontoone by 11.9% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after acquiring an additional 14,072 shares during the period. Perceptive Advisors LLC boosted its stake in shares of Billiontoone by 26.1% during the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after acquiring an additional 19,000 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in shares of Billiontoone during the 1st quarter worth approximately $4,046,000.

Insider Buying and Selling at Billiontoone

In other news, CTO David Tsao sold 20,000 shares of Billiontoone stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total transaction of $1,975,400.00. Following the completion of the sale, the chief technology officer owned 1,000 shares of the company’s stock, valued at approximately $98,770. This trade represents a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the sale, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at approximately $2,739,000. The trade was a 61.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 249,025 shares of company stock valued at $27,387,892 in the last ninety days. 50.22% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on BLLN. Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings downgraded Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, October 8th. Canaccord Genuity Group assumed coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price objective for the company. Zacks Research upgraded shares of Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and an average price target of $126.25.

Billiontoone Price Performance

Billiontoone stock opened at $101.03 on Tuesday. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The stock’s 50 day moving average is $101.04 and its 200-day moving average is $101.96. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $4.77 billion and a price-to-earnings ratio of 144.33.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Equities research analysts expect that Billiontoone, Inc. will post 0.80 EPS for the current year.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.